Chapters

Related Pages
Chapter 1: Diphtheria
Chapter 2: Haemophilus influenzae type b (Hib)
Chapter 3: Hepatitis A
Chapter 4: Hepatitis B
Chapter 5: Human Papillomavirus (HPV)
Chapter 6: Influenza
Chapter 7: Measles
Chapter 8: Meningococcal Disease
Chapter 9: Mumps
Chapter 10: Pertussis
Chapter 11: Pneumococcal
Chapter 12: Poliomyelitis
Chapter 13: Rotavirus
Chapter 14: Rubella
Chapter 15: Congenital Rubella Syndrome
Chapter 16: Tetanus
Chapter 17: Varicella
Chapter 18: Surveillance Indicators
Chapter 19: Enhancing Surveillance
Chapter 20: Analysis of Surveillance Data
Chapter 21: Surveillance for Adverse Events Following Immunization Using the Vaccine Adverse Event Reporting System (VAERS)
Chapter 22: Laboratory Support for Surveillance of Vaccine-Preventable Diseases
Chapter 23: National Surveillance of Vaccine-preventable Diseases
Chapter 24: State-specific Surveillance of Vaccine-preventable Diseases
Page last reviewed: June 29, 2020
Content source: National Center for Immunization and Respiratory Diseases